Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Versus Delayed BCG Vaccination of HIV-exposed Infants
NCT02062580Phase 2Completed
- Sponsor
- University of Cape Town
- Start
- Jun 2010
- Primary completion
- Apr 2012
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 2, randomised, open-label trial of bcg vaccine in Tuberculosis (TB) (2 arms), sponsored by University of Cape Town. Primary endpoint: T Cell Activation at 6 weeks. Started Jun 2010; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02062580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062580.